The Clorox Company $CLX Shares Bought by Harbour Investments Inc.

Harbour Investments Inc. raised its stake in The Clorox Company (NYSE:CLXFree Report) by 123.8% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 10,646 shares of the company’s stock after acquiring an additional 5,890 shares during the period. Harbour Investments Inc.’s holdings in Clorox were worth $1,073,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently bought and sold shares of CLX. Center for Financial Planning Inc. acquired a new position in Clorox in the third quarter valued at approximately $25,000. Vermillion & White Wealth Management Group LLC acquired a new position in Clorox in the third quarter valued at approximately $25,000. Darwin Wealth Management LLC acquired a new position in Clorox in the second quarter valued at approximately $29,000. Vision Financial Markets LLC boosted its stake in Clorox by 166.7% in the fourth quarter. Vision Financial Markets LLC now owns 320 shares of the company’s stock valued at $32,000 after acquiring an additional 200 shares during the period. Finally, Ameriflex Group Inc. boosted its stake in Clorox by 1,436.8% in the third quarter. Ameriflex Group Inc. now owns 292 shares of the company’s stock valued at $36,000 after acquiring an additional 273 shares during the period. 78.53% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In other news, Director Pierre R. Breber bought 5,000 shares of the company’s stock in a transaction that occurred on Tuesday, May 5th. The shares were purchased at an average price of $85.82 per share, with a total value of $429,100.00. Following the completion of the acquisition, the director directly owned 18,000 shares in the company, valued at approximately $1,544,760. This trade represents a 38.46% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 0.63% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

A number of brokerages have commented on CLX. TD Cowen lifted their target price on Clorox from $98.00 to $111.00 and gave the company a “hold” rating in a research note on Tuesday, March 31st. Rothschild & Co Redburn set a $117.00 price target on Clorox in a report on Friday, February 13th. Wall Street Zen raised Clorox from a “sell” rating to a “hold” rating in a report on Saturday, February 7th. The Goldman Sachs Group reaffirmed a “sell” rating and set a $83.00 price target on shares of Clorox in a report on Friday, May 1st. Finally, Weiss Ratings raised Clorox from a “sell (d+)” rating to a “hold (c-)” rating in a report on Monday, April 13th. One investment analyst has rated the stock with a Buy rating, eleven have assigned a Hold rating and five have given a Sell rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Reduce” and an average target price of $103.40.

View Our Latest Stock Analysis on CLX

Clorox Stock Performance

CLX opened at $89.98 on Friday. The business’s 50 day moving average is $98.46 and its 200-day moving average is $105.81. The stock has a market cap of $10.88 billion, a PE ratio of 14.61, a price-to-earnings-growth ratio of 0.50 and a beta of 0.59. The company has a current ratio of 0.84, a quick ratio of 0.65 and a debt-to-equity ratio of 27.03. The Clorox Company has a twelve month low of $84.70 and a twelve month high of $132.03.

Clorox (NYSE:CLXGet Free Report) last released its quarterly earnings results on Thursday, April 30th. The company reported $1.64 earnings per share for the quarter, beating analysts’ consensus estimates of $1.55 by $0.09. Clorox had a return on equity of 443.64% and a net margin of 11.18%.The company had revenue of $1.67 billion for the quarter, compared to analysts’ expectations of $1.67 billion. During the same quarter in the previous year, the company posted $1.45 earnings per share. The business’s revenue for the quarter was up .1% compared to the same quarter last year. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. On average, analysts predict that The Clorox Company will post 5.61 earnings per share for the current year.

About Clorox

(Free Report)

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.

Read More

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.